Business · 11/03/1994Updated: 10/15/2026 · 1 min read
Determination of Regulatory Review Period for Purposes of Patent Extension; Sporanox Register
Summary
The Food and Drug Administration (FDA) has determined the regulatory review period for Sporanox and published this notice as required by law following an application for patent extension.
Original source language: Federal Register — Health and Human ServicesOpen original release →